{
    "title": "The Efficacy Of Everything In Psychiatry In One Graph Plus Several Pages Of Dense But Necessary Explanation",
    "date": "February 8, 2015",
    "links": [
        "https://slatestarcodex.com/blog_images/forestplotpaper.pdf",
        "https://slatestarcodex.com/2013/09/19/scientific-freud/",
        "http://www.ncbi.nlm.nih.gov/pubmed/22297588",
        "https://slatestarcodex.com/2015/02/01/talents-part-2-attitude-vs-altitude/",
        "http://www.health.harvard.edu/blog/common-anticholinergic-drugs-like-benadryl-linked-increased-dementia-risk-201501287667"
    ],
    "url": "https://slatestarcodex.com/2015/02/08/the-efficacy-of-everything-in-psychiatry-in-one-graph-plus-several-pages-of-dense-but-necessary-explanation/",
    "summary": "Key ideas:\n- Huhn et al (2014) graph the Efficacy Of Pharmacotherapy And Psychotherapy For Adult Psychiatric Disorders\n- The effect sizes are mostly around 0.5, which is equal to average effect sizes in other fields of medicine\n- Drugs are more effective than therapy in treating borderline personality disorder and insomnia\n- In all conditions, drugs seem more effective at preventing relapse than at stopping acute episodes\n- Psychotherapy trials were generally of lower quality, giving people \"placebo psychotherapy\" is more complicated than giving people a sugar pill\n- Publication bias is worse for pharmacotherapy trials than psychotherapy trials\n\nKey learnings:\n- Therapy may not work as well in certain conditions, such as borderline personality disorder and insomnia\n- It's important to consider the quality of the trials when looking at the effectiveness of a treatment\n- Publication bias can impact the reporting of positive findings in pharmacotherapy trials\n\nKey questions:\n- What is the impact of the sample size on the efficacy of the treatment?\n- How can the quality of psychotherapy trials be improved?\n- Why is publication bias worse for pharmacotherapy trials than psychotherapy trials?"
}